@article{cc2226bda7da4a5a9d7de736766713ed,
title = "REVERSIBILITY OF LYMPHOMAS AND LYMPHOPROLIFERATIVE LESIONS DEVELOPING UNDER CYCLOSPORIN-STEROID THERAPY",
abstract = "Post-transplant lymphomas or other lymphoproliferative lesions, which were usually associated with Epstein-Barr virus infections, developed in 8, 4, 3, and 2 recipients, respectively, of cadaveric kidney, liver, heart, and heart-lung homografts. Reduction or discontinuance of immunosuppression caused regression of the lesions, often without subsequent rejection of the grafts. Chemotherapy and irradiation were not valuable. The findings may influence policies about treating other kinds of post-transplantation neoplasms.",
author = "Starzl, {T. E.} and Porter, {K. A.} and S. Iwatsuki and Rosenthal, {J. T.} and Shaw, {B. W.} and Atchison, {R. W.} and Nalesnik, {M. A.} and M. Ho and Griffith, {B. P.} and Hakala, {T. R.} and Hardesty, {R. L.} and R. Jaffe and Bahnson, {H. T.}",
note = "Funding Information: We thank ProfM. A. Epstein for performing some of the EBNA studies, Dr G. Miller and Dr J. Pagano for the DNA-DNA hybridisations, and Ms Judy Burnham, Mr G. Haffenden, and Mr N. MacHugh for their excellent technical help. We gratefully acknowledge the collaboration of the following pathologists: R. H. Fennell (University of Colorado), B. Rabin (University of Pittsburgh), and S. Miller (Allegheny Valley Hospital, Natrona Heights, PA). The work was supported by research grants from the Veterans Administration, by project grants no AM-29961 and AI-19377 from the National Institutes of Health, and by grant no RR-00084 from the General Clinical Research Centers Program of the Division of Research Resources, National Institutes of Health, Bethesda, Maryland.",
year = "1984",
month = mar,
day = "17",
doi = "10.1016/S0140-6736(84)90994-2",
language = "English (US)",
volume = "323",
pages = "583--587",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Elsevier Limited",
number = "8377",
}